MIP Diagnostics Limited develops and manufactures nanoMIPs, linear MIPs, bulk MIP and Rationally Designed Polymers using its proprietary processes.
Molecularly Imprinted Polymers (MIPs) are ‘synthetic’ affinity reagents and the nanoMIP format provides a more robust alternative to antibodies, typically with similar or greater affinity coupled with additional unique characteristics.
Business funding insights
BGF explains: Is private equity the best way to fund an M&A growth strategy?
What to consider when seeking private equity funding for acquisitive growth, from investment timelines to deal types and more
BGF explains: what do private equity investors look for in a business?
We explain what private equity investors look for in the businesses they invest in, from your growth plan to your management team.